These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The phosphatase PHLPP controls the cellular levels of protein kinase C. Gao T; Brognard J; Newton AC J Biol Chem; 2008 Mar; 283(10):6300-11. PubMed ID: 18162466 [TBL] [Abstract][Full Text] [Related]
6. PHLPP Signaling in Immune Cells. Lordén G; Lam AJ; Levings MK; Newton AC Curr Top Microbiol Immunol; 2022; 436():117-143. PubMed ID: 36243842 [TBL] [Abstract][Full Text] [Related]
7. Detection of PHLPP1α/β in human and mouse brain by different anti-PHLPP1 antibodies. Jackson TC; Bayir H; Ikonomovic MD; Janesko-Feldman K; Mi Z; Gao T; Jackson EK; Kochanek PM Sci Rep; 2015 Apr; 5():9377. PubMed ID: 25827478 [TBL] [Abstract][Full Text] [Related]
8. PHLPPing through history: a decade in the life of PHLPP phosphatases. Grzechnik AT; Newton AC Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677 [TBL] [Abstract][Full Text] [Related]
9. Pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP): a new player in cell signaling. Warfel NA; Newton AC J Biol Chem; 2012 Feb; 287(6):3610-6. PubMed ID: 22144674 [TBL] [Abstract][Full Text] [Related]
10. Turning off AKT: PHLPP as a drug target. Newton AC; Trotman LC Annu Rev Pharmacol Toxicol; 2014; 54():537-58. PubMed ID: 24392697 [TBL] [Abstract][Full Text] [Related]
11. PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma. Molina JR; Agarwal NK; Morales FC; Hayashi Y; Aldape KD; Cote G; Georgescu MM Oncogene; 2012 Mar; 31(10):1264-74. PubMed ID: 21804599 [TBL] [Abstract][Full Text] [Related]
12. Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance. Andreozzi F; Procopio C; Greco A; Mannino GC; Miele C; Raciti GA; Iadicicco C; Beguinot F; Pontiroli AE; Hribal ML; Folli F; Sesti G Diabetologia; 2011 Jul; 54(7):1879-87. PubMed ID: 21461637 [TBL] [Abstract][Full Text] [Related]
13. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Brognard J; Sierecki E; Gao T; Newton AC Mol Cell; 2007 Mar; 25(6):917-31. PubMed ID: 17386267 [TBL] [Abstract][Full Text] [Related]
14. PHLPP phosphatases as a therapeutic target in insulin resistance-related diseases. Hribal ML; Mancuso E; Spiga R; Mannino GC; Fiorentino TV; Andreozzi F; Sesti G Expert Opin Ther Targets; 2016 Jun; 20(6):663-75. PubMed ID: 26652182 [TBL] [Abstract][Full Text] [Related]
15. Photoreceptor Neuroprotection: Regulation of Akt Activation Through Serine/Threonine Phosphatases, PHLPP and PHLPPL. Rajala RV; Kanan Y; Anderson RE Adv Exp Med Biol; 2016; 854():419-24. PubMed ID: 26427440 [TBL] [Abstract][Full Text] [Related]
16. Mislocalization of the E3 ligase, β-transducin repeat-containing protein 1 (β-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt. Warfel NA; Niederst M; Stevens MW; Brennan PM; Frame MC; Newton AC J Biol Chem; 2011 Jun; 286(22):19777-88. PubMed ID: 21454620 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of PHLPP1/2 phosphatases rescues pancreatic β-cells in diabetes. Lupse B; Annamalai K; Ibrahim H; Kaur S; Geravandi S; Sarma B; Pal A; Awal S; Joshi A; Rafizadeh S; Madduri MK; Khazaei M; Liu H; Yuan T; He W; Gorrepati KDD; Azizi Z; Qi Q; Ye K; Oberholzer J; Maedler K; Ardestani A Cell Rep; 2021 Aug; 36(5):109490. PubMed ID: 34348155 [TBL] [Abstract][Full Text] [Related]
18. PHLiPPing the switch on Akt and protein kinase C signaling. Brognard J; Newton AC Trends Endocrinol Metab; 2008 Aug; 19(6):223-30. PubMed ID: 18511290 [TBL] [Abstract][Full Text] [Related]
19. PHLPPing the Script: Emerging Roles of PHLPP Phosphatases in Cell Signaling. Baffi TR; Cohen-Katsenelson K; Newton AC Annu Rev Pharmacol Toxicol; 2021 Jan; 61():723-743. PubMed ID: 32997603 [TBL] [Abstract][Full Text] [Related]
20. Regional hippocampal differences in AKT survival signaling across the lifespan: implications for CA1 vulnerability with aging. Jackson TC; Rani A; Kumar A; Foster TC Cell Death Differ; 2009 Mar; 16(3):439-48. PubMed ID: 19039330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]